The Educational Advisory Council invites you to submit educational sessions for the 2016 ASCP Annual Meeting & Exhibition to be held November 4 – 6, 2016 in Dallas, Texas.
The American Society of Consultant Pharmacists is seeking educational activity proposals that provide innovative ways to approach challenges experienced by pharmacists in a variety of settings. Senior care pharmacy practice is population specific rather than site specific and we encourage submissions that address a wide variety of practice settings (long-term care, skilled nursing facility, hospital, assisted living, ambulatory care center, and other settings). A submission will not be considered if the content is of a promotional nature. Incomplete submissions cannot be considered.
1. To submit a session proposal, indicate your agreement with the terms below by clicking on the statement at the bottom of this page.
2. The submission form should be filled out in its entirety. If the page is closed before the submission is complete, you will need to start over.
Partial submissions will not be considered.
3. The information needed to fill out the form includes:
ASCP will only consider submissions for education sessions that are submitted using the online process by Friday, February 19, 2016.
Any questions should be directed to firstname.lastname@example.org.
Presenters will receive notification of decision regarding submission via email and can expect notification by April 30, 2016.
All submitters will be asked to confirm acceptance of the Educational Advisory Council’s invitation.
Complimentary meeting registration will be provided for a maximum of 2 presenters for each accepted submission. ASCP greatly values your willingness to share your findings; however, we are unable to support any expenses related to participation.
General Submission Categories
The following general categories include topics that members and attendees have told us they want addressed in conference sessions. The topics listed are only suggestions and should not limit your proposal. Topics that address innovative solutions to ongoing problems and challenges as well as topics that focus on practical, real-world application information possessing immediate take-home value are recommended.
Please note that some submitted sessions may be combined depending on the topic and material and available slots. The committee works hard to make decisions considering many variables, and not all submitted sessions can be accepted.
Business Management and Operations
These sessions address business challenges that pharmacists face in their daily practices. Reimbursement, personnel management, billing, and productivity issues would be some of the topics that fall into this category.
These sessions incorporate information designed to strengthen knowledge in identifying disorders commonly seen in the senior population. Topics in this category might include communication skills, compliance packaging issues, role of the caregiver in medication management, and a pharmacist’s decision-making process in consideration of a patient’s cognitive and/or functional status, common diseases, disorders and syndromes seen in the elderly population; observational and assessment skills; and ethical issues, such as end-of-life care.
These sessions address a pharmacist’s advanced knowledge of the medications used to treat common diseases and conditions in geriatric patients. Topics in this category might include review of specific classes of medications used to treat common geriatric disorders including age-related pharmacologic changes or the impact of selection and dosing of medications in the geriatric population.
Legislative and Regulatory Affairs
These sessions are intended to help pharmacists and providers of pharmacy services to the elderly understand new legislative initiatives, legal issues, and regulatory processes that impact the complex senior care environment.
High Priority Topics Identified by ASCP’s 2016 Needs Assessment Survey
ASCP’s 2016 Needs Assessment identified the following specific topics/areas as high priority areas for our members and meeting attendees:
Presentations are approximately 60-90 minutes in length. An individual or panel gives the presentation to an audience of 50-300 participants in a classroom style setting. Interdisciplinary panel discussion formats and case-based presentations are of high interest.
In accordance with the standards set forth by the Accreditation Council for Pharmacy Education (ACPE) it is the policy of the American Society of Consultant Pharmacists (ASCP) to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities including those that are sponsored and cosponsored.
Faculty are expected to disclose all relevant financial relationships with any commercial interest. Definitions of the following terms are set forth by the ACPE.
All CPE activities offered by ASCP shall exhibit fair and balanced content, providing the audience with information of different perspectives from which to develop an informed professional opinion. If a conflict of interest exists, presenters must base their presentations on the best available evidence and be prepared to have some or all materials reviewed by peers.
In consideration of the American Society of Consultant Pharmacists (ASCP) taking action in reviewing my (our) submission, the authors(s) listed above hereby transfer(s), assign(s), and otherwise convey(s) all ownership rights in the submission and all copyright ownership to the ASCP. In the event that such work is not accepted by ASCP, all said rights shall be released. This grants ASCP first publication rights in the submission.
I understand that contributed session presenters do not receive financial support to attend the meeting and that I cannot pursue commercial support to do so. However, complimentary meeting registration will be provided.
Recording Agreement for Session Presenters
I (we) authorize the recording of my (our) presentation and further authorize unedited and/or edited recordings of my (our) presentation(s) for ASCP's archival purposes without compensation to me (us).
I have read and understand all criteria pertaining to the submission process including disclosure of financial support, financial assistance and copyright rights. Submission electronically implies consent with these terms and individual author/presenters signatures are not required.